Abstract:Background: Huntington's disease (HD), caused by polyglutamine expansion in huntingtin (Htt), results in severe neurodegeneration in the striatum, and to a lesser extent, cortex and hippocampus. In contrast, non-expanded huntingtin (wildtype, wtHtt) enhances pro-survival trophic factor BDNF expression and protects striatal neurons from excitotoxicity, a mechanism thought to contribute to HD pathophysiology; however, it is unknown whether these effects of wtHtt extend to other brain areas. Objective: Test wtHtt's role in pro-survival signaling and neuroprotection in striatum, cortex and hippocampus. Methods: Levels of nuclear phosphorylated cAMP response element-binding protein (pCREB), a regulator of pro-survival gene transcription, and resistance to NMDA-induced apoptosis in primary neuronal cultures - hippocampal and corticostriatal co-culture -were assessed using immunocytochemistry and excitotoxicity assays, respectively. Cultures from wild-type FVB/N (WT) mice were compared with those from YAC18 mice on an FVB/N background, expressing both human, full-length wtHtt and normal levels of murine Htt. Results: Basal pCREB was higher in YAC18 striatal but not cortical or hippocampal neurons; however, all three types showed decreased apoptosis in YAC18 vs. WT cultures. Increased striatal neuronal pCREB required wtHtt overexpression in both cortical and striatal neurons. Reduced response to exogenous BDNF, or its soluble scavenger TrkB-Fc, suggested enhanced BDNF signaling contributes to increased YAC18 striatal pCREB. Conclusion: Basal pro-survival signaling does not predict neuronal vulnerability to apoptosis in our culture system, since wtHtt overexpression elevates basal pCREB selectively in striatal neurons but is more globally neuroprotective. These results extend knowledge of the physiological roles of huntingtin, facilitating development of HD therapeutics.

Protective Effect of Sodium Butyrate on the Cell Culture Model of Huntington Disease

L-3-n-Butylphthalide Protects HSPB8 K141N Mutation-Induced Oxidative Stress by Modulating the Mitochondrial Apoptotic and Nrf2 Pathways

Sodium Butyrate Ameliorates Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy

Progress in studies of gene therapy for Huntington's disease

Inhibition of Neurite Outgrowth and Promotion of Cell Death by Cytoplasmic Soluble Mutant Huntingtin Stably Transfected in Mouse Neuroblastoma Cells

Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunction

Sodium Butyrate Exerts Antioxidant Stress Effects and Attenuates Aβ25-35-induced Cytotoxicity in PC12 Cells.

Therapeutic Effect Of Berberine On Huntington'S Disease Transgenic Mouse Model

Study on the toxic effects of Aβ1-42 oligomers in SHSY5Y with human A53T mutant α-synuclein over-expression.

Rapid and high-purity differentiation of human medium spiny neurons reveals LMNB1 hypofunction and subtype necessity in modeling Huntington’s disease

Sodium Butyrate Protects N2a Cells Against Aβ Toxicity in Vitro

Region-specific pro-survival signaling and global neuronal protection by wild-type Huntingtin

Xyloketal-Derived Small Molecules Show Protective Effect by Decreasing Mutant Huntingtin Protein Aggregates in Caenorhabditis Elegans Model of Huntington'S Disease

Pathological Cell-Cell Interactions Are Necessary for Striatal Pathogenesis in a Conditional Mouse Model of Huntington's Disease.

Butyrate Ameliorates Mitochondrial Respiratory Capacity of The Motor-Neuron-like Cell Line NSC34-G93A, a Cellular Model for ALS

A Novel Human Embryonic Stem Cell‐derived Huntington's Disease Neuronal Model Exhibits Mutant Huntingtin (mhtt) Aggregates and Soluble Mhtt‐dependent Neurodegeneration

Sodium Butyrate Ameliorates Histone Hypoacetylation and Neurodegenerative Phenotypes in a Mouse Model for DRPLA

Treatment of spinal muscular atrophy by sodium butyrate

CRISPR/Cas9-mediated Gene Editing Ameliorates Neurotoxicity in Mouse Model of Huntington’s Disease

Expression of Mutant N-terminal Huntingtin Fragment (Htt552-100Q) in Astrocytes Suppresses the Secretion of BDNF

Neuroprotective Effects of Methyl 3,4-Dihydroxybenzoate against TBHP-Induced Oxidative Damage in SH-SY5Y Cells